London Daily

Focus on the big picture.
Friday, Nov 28, 2025

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Pandemic-hit NHS wastes over £560mn yearly on ‘unnecessary’ & addictive pills with severe withdrawal symptoms – study

Despite the Covid pandemic, the NHS is reportedly wasting as much as £568 million yearly on habit-forming drugs like painkillers and sleeping pills that the majority of patients do not need, leading to dangerous addictions.

Doctors in England are unnecessarily pushing dependency-causing opioids, antidepressants and other pills, according to a new study by the Council for Evidence-based Psychiatry (CEP). Researchers found that three in four prescriptions were totally unnecessary in some cases.

The study, published on Tuesday in the journal Addictive Behaviours, revealed that, for many patients, their symptoms were not severe enough to warrant such medication. In other cases, safer options of treatment, such as counselling or less toxic drugs, were not fully explored while there were also instances of patients who were put on the pills for longer than required.

“Money is being wasted at a time when the health service is strapped for cash. The NHS is not taking this problem seriously and many doctors don’t appreciate the extent to which withdrawal from these medicines is a problem,” Dr James Davies, the study’s co-lead author, told the Daily Mail.


Between 2015 and 2018, the study estimated, there was a taxpayer bill of £1.7 billion for prescriptions for antidepressants, opioids, gabapentinoids, benzodiazepines and Z-drugs (sleeping pills). The total costs accounted for the price of the drugs, the average consultation cost (about £33) of seeing a General Practitioner (GP), and dispensing fees.

NHS figures reportedly show that nearly 17 million people a year in the country are getting a prescription for such drugs. The level of waste is so colossal that it could go towards paying the salaries of another 10,000 GPs or 20,000 nurses, according to the Daily Mail, which reported that the Department of Health and Social Care is yet to finalise plans to tackle the issue.

Nearly half the taxpayer money being wasted each year – to the tune of £288 million – goes towards highly addictive opioid painkillers followed by £158 million a year for gabapentinoids. But the researchers, from Roehampton University, Greenwich University and University College London, warn that it is likely the total amount lost is far higher than the “conservative” estimates in the study.

In addition, the study does not account for the significant costs related to harms caused by habit-forming drugs. These include higher disability payments and lost tax revenues, as well as workplace absenteeism and decreased productivity.

Besides the financial losses, unnecessary prescription also exacts a human cost: when people try to kick the habit, they suffer severe withdrawal symptoms, including stomach cramps, blurred vision and loss of appetite. For instance, studies on benzodiazepine usage reportedly show that 50% of those on the drugs for as little as four weeks suffer anxiety, dizziness, concentration problems, nightmares and weakness. That figure rises to 100% for people taking the medication for over six months.

Commenting on the study, Tory MP Danny Kruger, who chairs the All Party Parliamentary Group for Prescribed Drug Dependence, said that a “fraction of these wasted costs should now be invested in a helpline and dedicated withdrawal support services.”

In 2019, a Public Health England report revealed that “hundreds of thousands” of patients had become dependent on medicines and recommended face-to-face support, better training for doctors on the risks of drug dependency, and a 24-hour helpline on how to reduce medication.

While little action has occurred since, a Department of Health and Social Care spokesman told the Daily Mail that ministers are finally backing plans for a helpline and will be “working closely” with the NHS to implement the recommendations.

Newsletter

Related Articles

0:00
0:00
Close
250 Still Missing in the Massive Fire, 94 Killed. One Day After the Disaster: Survivor Rescued on the 16th Floor
Trump: National Guard Soldier Who Was Shot in Washington Has Died; Second Soldier Fighting for His Life
UK Chancellor Reeves Defends Tax Rises as Essential to Reduce Child Poverty and Stabilise Public Finances
No Evidence Found for Claim That UK Schools Are Shifting to Teaching American English
European Powers Urge Israel to Halt West Bank Settler Violence Amid Surge in Attacks
"I Would Have Given Her a Kidney": She Lent Bezos’s Ex-Wife $1,000 — and Received Millions in Return
European States Approve First-ever Military-Grade Surveillance Network via ESA
UK to Slash Key Pension Tax Perk, Targeting High Earners Under New Budget
UK Government Announces £150 Annual Cut to Household Energy Bills Through Levy Reforms
UK Court Hears Challenge to Ban on Palestine Action as Critics Decry Heavy-Handed Measures
Investors Rush Into UK Gilts and Sterling After Budget Eases Fiscal Concerns
UK to Raise Online Betting Taxes by £1.1 Billion Under New Budget — Firms Warn of Fallout
Lamine Yamal? The ‘Heir to Messi’ Lost to Barcelona — and the Kingdom Is in a Frenzy
Warner Music Group Drops Suit Against Suno, Launches Licensed AI-Music Deal
HP to Cut up to 6,000 Jobs Globally as It Ramps Up AI Integration
MediaWorld Sold iPad Air for €15 — Then Asked Customers to Return Them or Pay More
UK Prime Minister Sir Keir Starmer Promises ‘Full-Time’ Education for All Children as School Attendance Slips
UK Extends Sugar Tax to Sweetened Milkshakes and Lattes in 2028 Health Push
UK Government Backs £49 Billion Plan for Heathrow Third Runway and Expansion
UK Gambling Firms Report £1bn Surge in Annual Profits as Pressure Mounts for Higher Betting Taxes
UK Shares Advance Ahead of Budget as Financials and Consumer Staples Lead Gains
Domino’s UK CEO Andrew Rennie Steps Down Amid Strategic Reset
UK Economy Stalls as Reeves Faces First Budget Test
UK Economy’s Weak Start Adds Pressure on Prime Minister Starmer
UK Government Acknowledges Billionaire Exodus Amid Tax Rise Concerns
UK Budget 2025: Markets Brace as Chancellor Faces Fiscal Tightrope
UK Unveils Strategic Plan to Secure Critical Mineral Supply Chains
UK Taskforce Calls for Radical Reset of Nuclear Regulation to Cut Costs and Accelerate Build
UK Government Launches Consultation on Major Overhaul of Settlement Rules
Google Struggles to Meet AI Demand as Infrastructure, Energy and Supply-Chain Gaps Deepen
Car Parts Leader Warns Europe Faces Heavy Job Losses in ‘Darwinian’ Auto Shake-Out
Arsenal Move Six Points Clear After Eze’s Historic Hat-Trick in Derby Rout
Wealthy New Yorkers Weigh Second Homes as the ‘Mamdani Effect’ Ripples Through Luxury Markets
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
UK Unveils Critical-Minerals Strategy to Break China Supply-Chain Grip
Taylor Swift’s “The Fate of Ophelia” Extends U.K. No. 1 Run to Five Weeks
UK VPN Sign-Ups Surge by Over 1,400 % as Age-Verification Law Takes Effect
Former MEP Nathan Gill Jailed for Over Ten Years After Taking Pro-Russia Bribes
Majority of UK Entrepreneurs Regard Government as ‘Anti-Business’, Survey Shows
UK’s Starmer and US President Trump Align as Geneva Talks Probe Ukraine Peace Plan
UK Prime Minister Signals Former Prince Andrew Should Testify to US Epstein Inquiry
Royal Navy Deploys HMS Severn to Shadow Russian Corvette and Tanker Off UK Coast
China’s Wedding Boom: Nightclubs, Mountains and a Demographic Reset
Fugees Founding Member Pras Michel Sentenced to 14 Years in High-Profile US Foreign Influence Case
WhatsApp’s Unexpected Rise Reshapes American Messaging Habits
United States: Judge Dressed Up as Elvis During Hearings – and Was Forced to Resign
Johnson Blasts ‘Incoherent’ Covid Inquiry Findings Amid Report’s Harsh Critique of His Government
Lord Rothermere Secures £500 Million Deal to Acquire Telegraph Titles
Maduro Tightens Security Measures as U.S. Strike Threat Intensifies
U.S. Envoys Deliver Ultimatum to Ukraine: Sign Peace Deal by Thursday or Risk Losing American Support
×